The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...
The code encompasses the Sonata ® Procedure, an innovative, incision-free treatment for symptomatic uterine fibroids that leverages Gynesonics' proprietary Radiofrequency (RF ... The Sonata ® ...
Stereotaxis' latest regulatory approval in China is likely to offer a minimally-invasive treatment solution for complex arrhythmia patients and improve global cardiovascular care.
Your doctor may recommend a cardiac-focused physical therapy program if you’ve had a heart attack. The program may last 2 to 8 months. Research shows it may reduce your risk of experiencing more ...
When medication fails to help, ablation is already the go-to remedy. It uses radiofrequency energy to destroy the abnormal tissue causing VT, while leaving the rest of the heart undamaged.